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Introduction 
Carnitine (L-3-hydroxytrimethylamminobutan 
oate) (Figure 1) is an endogenous compound 
with a specific role in the metabolism: it is 
derived from food sources as well as from 
endogenous biosynthesis. Important dietary 
sources of this compound, are meat and dairy 
products (Rebouche et al., 1984). Lysine 
supply the biosynthetic precursor of the 
carbon backbone of carnitine; the final step of 
its biosynthesis, occurs in the liver and kidney 
(Rebouche et al., 1986).  
The loss of carnitine in humans occurs 
through urinary excretion of carnitine and 
acylcarnitine. Carnitine and acylcarnitine are 
both filtered and reabsorbed in the renal 
tubule (Ohtani et al., 1984). Different tissues 
have different transport systems (Brass E et al 
1992), which imply a difference in the content 
of carnitine in tissues, metabolic availability 
and turnover rates. 
The differences in the various tissues are 
emphasized by a comparison between the 
values of total carnitine (carnitine and 
acylcarnitine): for example in the plasma is 60 
mol/L, in the liver is 900 mmol/kg and in 
skeletal muscle is 4000 mmol/kg. The tissue 
of the myocardial and skeletal muscle 
represent the locations of greatest energy 
demand (Fraenkel and Friedman, 1957; 
Rebouche and Seim, 1998). 
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Abstract 
Carnitine is a compound that can be either endogenous, synthesized by the liver and kidneys, both 
exogenous, introduced with the diet, in particular through meat and dairy products. Carnitine has a dual 
role as it is required for long-chain fatty acid oxidation, and also shuttles accumulated acyl groups out of 
the mitochondria. Muscle requires optimization of both of these metabolic processes during peak exercise 
performance. Theoretically, carnitine availability may become limiting for either fatty acid oxidation or the 
removal of acyl-CoAs during exercise. Despite the theoretical basis that carnitine supplementation 
improves performance of exercise, clinical data have not shown significant benefits in this regard in 
healthy subjects, nor for strength performance, nor for endurance performance. 
Keywords: Carnitine, supplementation, fatty acid oxidation, FABPc, β-HAD performance. 
doi: 10.12863/ejssax1x1-2013x2 Section B 
  
55 
 
 
EJSS Journal 2013 1(1):54-64 - ISSN 2282-5673 
Febbraio V., Contrò V. and Proia P. 
 
 
Carnitine can be synthesized in the kidney 
and liver thanks to the action of the enzyme 
Acetil-L-Carnitine transferase (ALC 
transferase) from lysine, methionine, vitamin 
C and other substances that act as a substrate 
or cofactors.  
The carnitine complex is in the L-carnitine, its 
esters (L-propionilcarnitine and L-
acetylcarnitine) and by an articulated enzyme 
system, which is located at the level of the 
mitochondrial membrane, and includes: 
Carnitine palmitoyltransferase I and II (CPT 
I-II), Carnitine/acylcarnitine translocase (CT), 
carnitine acetyl transferase (CAT). 
 
Figure 1 Carnitine structure 
Why carnitine is used to improve the 
performance? 
Various specific methods have been studied 
to explain the effects of carnitine on athletic 
performance. The role of carnitine on 
mitochondrial oxidation of fatty acids 
suggests that supplementation could increase 
the oxidation, thereby increasing the ATP 
available for the mechanical work (Gorostiaga 
et al., 1989).  
The β-oxidation process consists in sequential 
shortening of the fatty acid chain with 
production of acetyl-CoA. Since the activated 
long chain fatty acids are not able to cross the 
inner mitochondrial membrane, the process of 
shortening of their chain is preceded by their 
carnitine-dependent transport that are 
activated in mitochondrial transmembrane 
space.  
The process start with the formation of acyl-
CoA by acyl-CoA synthetase (LCAS) that is 
localized in the external mitochondrial 
membrane. Subsequently is involved a 
voltage-dependent anion channel through 
which the movement of fatty acids activated 
takes place through the external mitochondrial 
membrane. In this step, fatty acids are 
processed in acylcarnitine with CPT-I enzyme 
it also localized in the external mitochondrial 
membrane. The reaction products, carnitine 
esters, are transported into the mitochondrial 
matrix through an exchange reaction in which 
is involved carnitine-acylcarnitine translocase 
(CACT), a protein located in the inner 
membrane. 
Inside the matrix, the esters of acylcarnitine 
are transformed in their respective CoA esters 
through CPT-II enzyme, an isoform of CPTI 
enzyme, that is associated with the inner side 
of mitochondrial membrane. The β-oxidation 
process of very long chain fatty acids occurs 
mainly in peroxisomes; while, the long-chain 
fatty acids are oxidized both in peroxisomes 
and in mitochondria.  
However, unlike the mitochondrial β-
oxidation, the oxidation of fatty acids that 
occurs in peroxisomes is incomplete, because 
it get acetil-CoA and acyl-CoA short and 
medium chain. Therefore, to obtain the 
complete oxidation to CO2, the products of 
peroxisomes should be transported into the 
mitochondria where esters of CoA will be 
finally oxidized in CO2 and H2O through the 
β-oxidation, the Krebs cycle and respiratory 
chain.  
If carnitine supplementation increase muscle 
oxidation of fatty acids, this could also delay 
the use of muscle glycogen and thus delay the 
onset of fatigue (Marconi C et al., 1985). 
Maintaining the rate of β-oxidation, carnitine 
allows the utilization of glucose and then 
preserves the muscle glycogen well as 
provides maximum production of ATP from 
metabolism of fats (Costill D et al., 1977).  
Different approaches have been used to 
evaluate the effect on fatty acid oxidation by 
carnitine supplementation. During an exercise 
perform below the anaerobic threshold, the 
respiratory quotient reflect the relative rate of 
glucose oxidation (Wasserman K, 1975); also 
  
 
 
EJSS Journal 2013 1(1):54-64 - ISSN 2282-5673 
Febbraio V., Contrò V. and Proia P. 
 
 
56 
the rate of oxygen consumption can be used 
to estimate the absolute velocity of oxidation 
of fatty acids (Livesey G et al., 1988). There 
are no experimental data which support that 
the assumption of carnitine increase fat 
oxidation or preserve muscle glycogen during 
exercises performance in healthy subjects. An 
alternative mechanism through which the 
carnitine could be taken to improve the 
physical performance, could be the 
production of short-chain acylcarnitine. The 
formation of acetylcarnitine dall'acetil-CoA, 
may represent an alternative product of the 
oxidation. 
The acetyl-CoA is the common product of 
glycolysis (from the oxidative 
decarboxylation of pyruvate) and β-oxidation 
of fatty acids: it is the substrate used for the 
next complete oxidation in the tricarboxylic 
acid cycle. If the production of acetyl-CoA 
exceeds the capability of use it in 
tricarboxylic acid cycle, there will be an 
increase of its concentration. This could 
inhibit the activity of pyruvate 
dehydrogenase, the enzyme that catalyzes the 
oxidation of pyruvate to acetyl-CoA (Bremer 
J, 1969). 
When the activity of pyruvate dehydrogenase 
decrease, pyruvate should reduced to lactate 
by the process of fermentation. During an 
high intensity exercise, there is a correlation 
between lactate accumulation and acetyl-CoA 
production (Constantin-Teodosiu et al., 1991). 
The production of acetylcarnitine could 
potentially control the content of acetyl-CoA 
through the inhibition of pyruvate 
dehydrogenase and increasing the availability 
of coenzyme A. The importance of the 
production of acetylcarnitine from 
mitochondrial oxidation has been 
demonstrated using in vitro approach. 
However, the demonstration of these effects 
depends of various conditions, not only 
physiological, including high concentrations 
of the endogenous carnitine. 
The esogenous high concentrations of 
carnitine, have no effect on maximum rates of 
oxidation and also on the content of the 
mitochondrial acetyl-CoA in liver and also in 
isolated mitochondria (EP Brass et al 1980). 
However, other experiments that increased 
several times hepatic carnitine content, had 
not effects on acetyl-CoA content, probably 
because it rapidly reaches equilibrium (EP 
Brass et al., 1980). The flow of pyruvate from 
pyruvate dehydrogenase action during an 
exercise near maximal loads of works, has 
been estimated at 1.9 mmol/kg in a minute 
(Putman et al., 1995). The decrease of acetyl-
CoA production, influence the rate of the 
oxidation of fatty acids and convert in only 2 
minutes the content of muscle carnitine (about 
4 mmol/kg) in acetylcarnitine. 
Furthermore, the quantity of carnitine 
necessary to support the net flow for another 
2 minutes, require twice content of muscle 
carnitine. Muscle fatigue is a process that 
involved many components from different 
points of view: psychological, metabolic and 
neural (Davis, 1995; Miller, 1995). Some 
studies showed that in some conditions the 
exogenous carnitine can decelerate loss of 
muscle contractile force (Brass et al., 1993). 
The correlation between metabolic effect of 
carnitine and increase of muscle fatty acid 
oxidation, with an increase of ATP synthesis, 
are remain unclear. So, despite the logic of the 
case and the availability of some supporting 
data, the theoretical basis of the efficacy of 
carnitine for improving muscle function must 
be explain. 
Effect of carnitine on athletic performance 
Several studies on the administration of 
carnitine were different as regards dose and 
duration of treatment; each of these 
parameters would provide some different 
benefit. These studies have involved many 
peoples who practices different sports and 
have different experience, age and sex. In 
addition, they monitoring different parameters 
as: maximum oxygen consumption (VO2 
max), athletic performance, perceived stress 
or metabolic parameters (for example 
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respiratory quotient, lactate accumulation or 
oxygen consumption at a fixed rate of work). 
Many studies showed that when 
supplementation lasted for a short term the 
effect on athletic performance were negative 
(Greig et al., 1987 Colombani et al., 1996). 
Actually, positive effects have been observed 
just in a long term supplementation. 
Particularly, it was determined that carnitine 
decrease the lactate accumulation when 
combined with exercise (Siliprandi N et al., 
1990), again reduced the VO2 max (Marconi 
et al., 1985; Vecchiet et al., 1990; Dragan et 
al., 1987) and also improving the fatty acids 
oxidation (Natali et al., 1993) (Table 1). 
The Arenas’s study (Arenas et al., 1994) 
emphasized the different effect of carnitine. It 
is important to underline that this work 
studied only athletes engaged in training 
programs for a period of 1 to 6 months. In 
these conditions, carnitine associated to 
training has showed to decrease in muscle 
carnitine content and simultaneously 
increased the activity of muscle enzymes, 
including pyruvate dehydrogenase and the 
enzymes of the respiratory chain. However, 
the physiological effect of these changes is 
still unknown and requires further 
investigation to confirm these preliminary 
results (Huertas R et al., 1992). 
Clinical trials on carnitine supplementation 
The bioavailability of orally administrated 
carnitine change roughly from 5 to 15% that 
is equivalent to small part of the portion that 
reaches the systemic circulation, in contrast to 
that assumed up by intravenous (Harper et al., 
1988 Segre et al., 1988).  
The content of total body carnitine in a 70 kg 
male is around 128 mmol or 20 g (Brass EP, 
1995). A large amounts of it taken orally are 
required, to change the endogenous reserves. 
Since the amount of these endogenous 
reserves are large, carnitine becomes 
important parameter in clinical trials. In fact, 
if 10% of the dose goes in the systemic 
circulation and 4% of the dose is excreted in 
the urine, its enough an oral administration of 
2 g for day, to induce a net increase of body 
reserves of 0.12 g per day (Segre et al 1988).  
So, after two weeks of carnitine 
administration there is an increase in body 
reserves of 8%. These estimates, highlight the 
importance in clinical trials on dosing 
parameters of carnitine. Cardiac factors or 
  
 
 
EJSS Journal 2013 1(1):54-64 - ISSN 2282-5673 
Febbraio V., Contrò V. and Proia P. 
 
 
58 
peripheral muscle may limit the maximum 
rate of oxygen consumption (VO2 max) and is 
dependent on the physiological characteristics 
of the subjects (Wasserman et al., 1975). 
During aerobic training, VO2 max variations 
occur as a result of alterations in the ability to 
perform physical tasks.  
The assessment of the performance in sports 
sustained exercise in regimens of resistance or 
specific activities have been used for groped 
to provide more generalizable results. A 
multiplicity of factors including the 
physiological conditions or the metabolic 
state of the subject affects on these activities; 
moreover, are less reproducible tests of 
maximal exercise. In studies on carnitine 
supplementation, have been analyzed several 
factors including muscle mass, enzymatic 
activity, muscle aches, respiratory quotient, 
oxygen consumption at a fixed workload. 
The data available to determine the effects of 
carnitine supplementation on physical 
performance, must have adequate statistical 
basis in order to detect the expected changes. 
Most of the studies on the effects of carnitine 
supplementation in healthy subjects have been 
recently examined (Table 2). Many of these 
have shown errors in the scientific design. In 
particular, the orally administration of 
carnitine has often been carried out for a 
period of 7/14 days and in some case, no 
more than 28 days (Brass EP, 1995). 
Furthermore, most of them has included less 
than ten subjects, and only in a few cases 
have been evaluated objective physiological 
parameters as VO2 max. Only five 
publications (Table 2) reported data about the 
effect of carnitine on this parameter. Two 
studies have been reported an increase in VO2 
max (Marconi et al., 1985; Vecchiet et al., 
1990) while other three studies showed no 
effect (Greig et al., 1987;Wyss et al., 1990; 
Hulsmsnn et al., 1992).  
Particularly, Vecchiet’s study, has 
documented that a single dose of carnitine one 
hour before exercise, increase VO2 max. In 
contrast, Hultman et al  underlined that it is 
extremely difficult to understand the action of 
a single oral dose of carnitine. 
The majority of studies found no effect of 
carnitine supplementation on metabolism or 
performance during exercise, considering 
certain parameters including the respiratory 
quotient to a fixed workload, the 
accumulation of lactate or the estimated cash 
substrate (Marconi et al., 1985; Oyono-
Enguelle et al., 1988; Décombaz et al., 1993; 
Vukovich, 1994; Wyss et al., 1990). XXXX 
The metabolic effects of carnitine 
supplementation are unclear, so it is unlikely 
that oral supplementation for a period up to 4 
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weeks, may change the physical performance 
in healthy subjects. The administration of 
carnitine in order to improve performance in 
athletes involved in specific activities such as 
competitive swimming or the marathon, has 
not demonstrated benefits (Trappe et al., 
1994; Colunbani et al., 1996). 
Again the Arenas’s studies (Arenas et al 1991 
J, Arenas J et al 1994) showed that oral 
supplemantation protracted for a periods from 
1 to 6 months, showed a correlation between 
exercise and a decrease in muscle carnitine 
content.   
Currently studies does not confirm that the 
use of carnitine may improve exercise 
performance in healthy subjects. This 
assumption cannot be considered definitively 
negative, due to limitations of the available 
studies. Future studies based on 
administration for long periods (more than 6 
months) optimized by monitoring important 
parameters, will demonstrate if there is an 
improvement in the performance of healthy 
subjects. 
Effect of carnitine supplementation in 
aerobic training 
The regular physical activity and carnitine 
supplementation, have a role in energy 
metabolism and can improve resistance 
capacity. Many studies on the combination 
between the prolonged ingestion of carnitine 
and physical training, detect some effects that 
involved cytosolic fatty acid-binding protein 
(FABPc) and β-hydroxyacyl-CoA 
dehydrogenase (β-HAD) enzyme, in skeletal 
muscle. 
The storage of carnitine may improve athletic 
performance; in fact a large number of studies 
have turned their concern to demonstrate how 
can increase fat oxidation and reduce the use 
of endogenous deposits of carbohydrates in 
endurance exercise afterwards L-carnitine 
supplementation (Barnett et al. 1994; Brass 
and Hoppel 1994; Gorostiaga et al. 1989; 
Heinonen 1996; Heinonen et al. 1992; 
Maassen et al. 1995; Marconi 1985; Soop et 
al. 1988; Trappe et al. 1994; Vukovich et al. 
1994; Wyss et al. 1990). 
Most of these studies, measured the oxidation 
of fatty acids during exercise through indirect 
calorimetry. The distribution of muscle fibers, 
can be considered an important indicator of 
oxidative capability. Muscle biopsies were 
made before and after training following 
administration; their influence on the fiber 
composition, were used to integrated the 
analysis. 
A biochemical marker of the capacity of fatty 
acids oxidation was the cytosolic fatty acid-
binding protein (FABPc) detection as an 
indicator of fatty acids oxidation in the 
muscle over which β-hydroxyacyl CoA 
dehydrogenase (β-HAD) works. 
Below is a study of 28 subjects in order to 
demonstrate the real effect on the 
performance played by carnitine. It included 
twenty-eight healthy volunteers who were 
randomly divided into four groups: a control 
group (CON, n=7 subjects); a group trained 
without the use of carnitine called "Exercise 
training" (ET, n=7 subjects); a group only 
supplemented with L-carnitine called 
"carnitine supplementation" (CS, n=7 
subjects); a group trained with 
supplementation of L-carnitine called 
"carnitine Execise Training" (CET, n=7 
subjects).  
The subjects on ET and CET groups, were 
trained for 40 minutes on a cycle ergometer at 
60% of maximum oxygen consumption (VO2 
max), at various times during six weeks. The 
groups supplemented, assumed 4 g/day of L-
carnitine as L-carnitine-tartrate. Muscle 
biopsies were made on vastus lateralis 
(Bergström, 1962).  The sample were store -
80° C until analysis were made. 
To highlight the myofibrillar activity, usually 
the transverse sections obtained from samples 
previously taken, were mounted on a 
coverslip and colored (Brooke and Kaiser 
1970). Were monitored muscle fibers of type 
I, IIa and IIx. 
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Furthermore were determined through an 
image analyser, the composition or cross-
section, the type of muscle fiber, the area of 
circulation, the relationship of the capillary 
fibers and capillary density.  
After treatment, the serum concentrations of 
triacylglycerols were increased almost 
twofold for groups ET and CET, while the 
subjects who took L-carnitine (group CS) 
showed no significant effect of 
triacylglycerols serum concentrations (figure 
2A). The total serum cholesterol was 
decreased in ET and CS subjects, but not in 
CET (figure 2B). 
The proportion of type I fibers, after 6 weeks 
of training, has remained unchanged in all 
groups except for group ET which showed an 
increase of 33% versus a decrease of the type 
II fibers (28%). The distribution of the fibers 
type IIa, only in the CET group there were an 
increased of the type IIx fibers; also, it was 
observed an increase in muscle fibers of the 
type IIa. 
After training the content in FABPc, remained 
unchanged nevertheless tends to increase in 
the ET group (35%) and decreases in the 
subjects of CON group (21%). In all groups 
the activity of -HAD was unchanged.  
In control group, the activity of -HAD was 
2.20 ± 0.51 mmol g/min. The activity of -
HAD, did not show any change in the ET 
group either as a result of regular exercise. 
When carnitine has been ingested for 6 weeks 
were obtained similar results and there was a 
18% increase in the activity of -HAD. 
Through this study it was shown that 
supplementation of carnitine had an additive 
effect on the phenotypic changes, muscle 
fiber type and size when combined with the 
training activity, but did not induce any 
further positive effect on the metabolism of 
fats. The concentration of carnitine in the 
muscles remain unchanged after its 
supplementation. 
 It was also demonstrated that, even the serum 
level of carnitine (after 3 days of the 
assumption of L-carnitine), the concentration 
of acyl L-carnitine remain the same 
confirming the results discussed above 
(Barnett et al., 1994; Brass et al., 1994; Natali 
et al., 1993; Trappe et al., 1994; Vukovich et 
al., 1994; Müller et al., 2002). Despite these 
positive changes, there was no increase in 
VO2 max, which is used to evaluate aerobic 
Figura 2: Concentration of total cholesterol (A); Activities of the -HAD (B) 
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capacity (Colombani et al., 1996; Trappe et 
al., 1994). 
In this study the physical exercises does not 
reduce the values of serum lipids. The 
prolonged aerobic exercise reduced serum 
lipid concentration (Kim et al, 2004; Cha et 
al., 2003). In subjects of the ET group 
increased the percentage of type I muscle 
fibers, while remained unchanged in the CS 
group. The muscle fibers IIa increased in CET 
group, although at the expense of the decrease 
in muscle fiber type IIx. 
The distribution of the different types of 
muscle fibers among the groups CON, CS, 
and ET were unchanged, except for CET 
group in which were observed an increase in 
muscle fiber type IIa and IIx. 
 This study conforms with the research of 
Sandra et al. (2002), demonstrated that the 
administration for three months of L-carnitine 
(2g for 2 times per day) did not induce any 
significant change in the composition of the 
muscle fibers.  
Furthermore, suggest that L-carnitine can lead 
to variations of the characteristics in the fibers 
fast-twitch when combined with exercise. The 
main stimulus is the training activity and 
physical stress, able to induce changes in the 
composition of the muscle fiber type observed 
in subjects of the group ET. 
During endurance exercise, the increased 
oxidation of fatty acids in the muscle  trained, 
it can be induced by increased activity and 
expression of FABPc  protein in the cell 
membrane (Kiens et al., 1993; 1997, Turcotte 
et al., 1992).  
The content of FABPc depends on external 
conditions such as training and the use of 
greater quantities of combustible. Higher 
concentrations are favorable to the 
characteristics of fast-twitch fibers (Clavel et 
al., 2002).  
The content of FABPc, had a trend of increase 
(53%) following the training  prolonged (even 
if not statistical significant), while the content 
of FABPc did not change afterwards carnitine 
supplementation. This results suggest that 
carnitine does not exert a deep effect on the 
expression of FABPc, which rather is 
correlated with exercise. To induce an 
increase in activity of the enzymes involved 
in both the citric acid cycle and -oxidation 
process is necessary to practice regular 
physical activity (Gollick and Saltin, 1982).  
However, contradictory results were obtained 
for example from another study in which a 
training group was able to increased -HAD 
activity (Kiens et al., 1993); but until now, 
there are nomore other studies that confirm 
this result (Bylund et al., 1977; Schantz et al., 
1983; Wibom et al., 1992; Lee et al., 2001). 
In summary, a phenotypic effect on the 
expression of the fibers and in the size of the 
muscles, can be induced by carnitine 
supplementation only in muscles that have 
glycolytic characteristics. 
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